|Follow-up (closed to accrual)
|Study Start Date:
|Study Made Public:
A Phase 2b study to evaluate the efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection
HVTN 703/HPTN 081 (AMP study) is a Phase IIb clinical trial to evaluate the safety and immunogenicity of VRC-HIVMAB060-00-AB (VRC01 mAb).
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.